Video yükleniyor...
Video Yüklenemedi
Moderna has just announced that its personalized cancer vaccine passed its Phase 3 clinical trial. The design process for this treatment was assisted by AI, which helped identify the specific proteins to target in each patient's tumor.
60,131 görüntüleme • 4 gün önce •via X (Twitter)
0 Yorum
Yorum bulunmuyor
Orijinal gönderinin yorumları burada görünecek
